within Pharmacolibrary.Drugs.ATC.N;

model N05AG03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.008166666666666666,
    adminDuration  = 600,
    adminMass      = 0.04,
    adminCount     = 1,
    Vd             = 0.0225,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0023333333333333335,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Penfluridol is a long-acting oral diphenylbutylpiperidine antipsychotic drug primarily used for maintenance therapy in chronic schizophrenia and other psychoses. Its prolonged action allows for once-weekly dosing. Although once used in several countries, penfluridol is now less commonly prescribed due to the availability of newer antipsychotics with more favorable side-effect profiles.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with schizophrenia after single oral doses.</p><h4>References</h4><ol><li><p>Migdalof, BH, et al., &amp; Janssen, PA (1979). Penfluridol: a neuroleptic drug designed for long duration of action. <i>Drug metabolism reviews</i> 9(2) 281–299. DOI:<a href=&quot;https://doi.org/10.3109/03602537908993895&quot;>10.3109/03602537908993895</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/385274/&quot;>https://pubmed.ncbi.nlm.nih.gov/385274</a></p></li><li><p>Grindel, JM, et al., &amp; Cressman, WA (1979). The comparative metabolism and disposition of penfluridol-3H in the rat, rabbit, dog, and man. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 7(5) 325–329. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/40775/&quot;>https://pubmed.ncbi.nlm.nih.gov/40775</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05AG03;
